Dicationic triaryl analogs as antiprotozoan agents

Details for Australian Patent Application No. 2004284091 (hide)

Owner Georgia State University Research Foundation, Inc University of North Carolina at Chapel Hill

Inventors Wilson, W. David; Tidwell, Richard R.; Mohamed, A. Ismail; Boykin, David W.; Brun, Reto

Agent Griffith Hack

Pub. Number AU-A-2004284091

PCT Pub. Number WO2005/040132

Priority 60/514,168 24.10.03 US

Filing date 25 October 2004

Wipo publication date 6 May 2005

International Classifications

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 235/18 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040132 Priority application(s): WO2005/040132

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284097-PIF peptides biologic activities, site of action, and the antibody to detect PIF

2004284090-LDL receptor class A and EGF domain monomers and multimers